Evidence map›Paper›PMID 40121149›Full record

ArticleJournal of immunological methods2025

Corrigendum to "Comprehensive normalization and binary classification methods for enhanced sensitivity and reproducibility in Luminex assay quantitation" [Journal of Immunological Methods 538 (2025) 113826].

B A Burns, C A Shaw, M Chandra, C S Forconi, A M Moormann, V Konduri, V N Tubman, W K Decker

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Journal of immunological methods, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

B A BurnsDepartment of Pathology & Immunology, Baylor College of Medicine, Houston, TX 77030, United States of America.
C A ShawDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, United States of America; Department of Statistics, Rice University, Houston, TX 77005, United States of America.
M ChandraDepartment of Pathology & Immunology, Baylor College of Medicine, Houston, TX 77030, United States of America.
C S ForconiDivision of Infectious Diseases in Immunology, Department of Medicine, University of Massachusetts Medical School, Worcester, MA 01605, United States of America.
A M MoormannDivision of Infectious Diseases in Immunology, Department of Medicine, University of Massachusetts Medical School, Worcester, MA 01605, United States of America.
V KonduriDepartment of Pathology & Immunology, Baylor College of Medicine, Houston, TX 77030, United States of America; Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX 77030, United States of America.
V N TubmanTexas Children's Cancer and Hematology Centers, Texas Children's Hospital, Houston, TX, United States of America; Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, United States of America.
W K DeckerDepartment of Pathology & Immunology, Baylor College of Medicine, Houston, TX 77030, United States of America; Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX 77030, United States of America; Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX 77030, United States of America. Electronic address: decker@bcm.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40121149

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.